INC Research

For over two decades, INC Research® has been providing therapeutically focused drug development services to customers around the globe.
Our Mission Statement reads:
We are an organization composed of therapeutically-focused high performance teams, led by world-class project managers and leaders, dedicated to helping our customers bring products to market in order to improve world health.
Therapeutic Expertise
Our team is built from the brightest people in the industry with years of Central Nervous System (CNS), Oncology, and industry-related experience, from our top scientists to our data entry group.
Customized Service
A customer-centric focus is a clear, common objective across our entire organization. We tailor our full range of services, processes and technology to the unique needs of each client and their specific project requirements. Our high percentage of repeat business is a testament to the quality and dedication of our team

Contact Details: 4700 Falls of Neuse RoadSuite 400 Raleigh North Carolina 27609 United States of America Tel: 919-876-9300 Fax: 919-876-9360 Email: jobs@incresearch.com WWW: www.incresearch.com/

Loading...

Recent Publications by INC Research:
Targeted therapies in the treatment of advanced non-small-cell lung cancer: update. After several years of clinical trials in the setting of advanced...	24th September, 2009	INC Research,	Klin Onkol. 2009;22(4):131-8.
Persistent expression of PEDF in the eye using high-capacity adenovectors. Ocular neovascularization, the growth of abnormal blood vessels in the...	8th January, 2009	GenVec, Inc. Research Department, Gaithersburg, Maryland 20878, USA.	Mol Ther. 2008 Dec;16(12):1986-94. Epub 2008 Sep 30. DOI Direct Link
Pregnancy outcomes after maternal exposure to simvastatin and lovastatin. BACKGROUND: Our objective was to determine the frequency of adverse...	13th April, 2006	Merck & Co., Inc. Research Laboratories, West Point, Pennsylvania	Birth Defects Res A Clin Mol Teratol. 2005 Nov;73(11):888-96. DOI Direct Link
Comparative hepatic toxicity: prechronic/chronic liver toxicity in rodents. The morphologic assessment of the gross and microscopic appearance of the...	7th June, 2005	Experimental Pathology Laboratories, Inc. Research Triangle Park, North	Toxicol Pathol. 2005;33(1):35-40. DOI Direct Link
The benefits divide: health care purchasing in retail versus other sectors. This paper is the first to compare health care purchasing in the retail...	31st October, 2002	John Snow, Inc. Research and Training Institute, Boston, USA.	Health Aff (Millwood). 2002 Sep-Oct;21(5):224-33.
→View more INC Research research publications.

Press Releases on INC Research:
MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations	1st July, 2009	MDS Inc.	MDS Pharma Services to Focus on the Delivery of Early Stage Services - Discovery Through Phase IIa TORONTO, July 1 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading
MDS Reports Second Quarter 2009 Financial Results	11th June, 2009	MDS Inc.	TORONTO, June 11 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the
MDS Announces Strategy to Focus MDS Pharma Services on Early Stage Operations - Discovery Through Phase IIa	1st June, 2009	MDS Inc.	Company to Divest Late Stage Operations, Signs Agreement to Sell Phase II-IV Operations to INC Research TORONTO, June 1 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading
Excaliard Pharmaceuticals Appoints Lincoln Krochmal, MD, President & Chief Executive Officer and Jeffrey Jenson, Head of Clinical Operations.	10th October, 2008	Excaliard Pharmaceuticals	CARLSBAD, Calif., Oct. 10 /PRNewswire/ -- Excaliard Pharmaceuticals, a late stage preclinical company developing targeted therapeutics for the treatment of dermatological disorders and fibrotic
US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services	25th August, 2008	US Oncology, Inc.	HOUSTON, Aug. 25 /PRNewswire/ -- US Oncology, Inc. today announced the appointment of Stephen Smith as Vice President/General Manager Research and Personalized Science Services. Smith will oversee

BioNews Results for INC Research:
Alcon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released	PR inside:  Nov 16 2009 6:25AM Matching: inc research
AspenBio Pharma, Inc. - Medical Equipment - Deals and Alliances Profile - new report released	PR inside:  Nov 16 2009 4:58AM Matching: inc research
Toray Industries, Inc. Donates 3D-Gene(TM) Competition Award 2009 to Encourage Scientists Using DNA Microarray	StockHouse USA:  Nov 16 2009 4:13AM Matching: inc research
Toray Industries, Inc. Donates 3D-Gene(TM) Competition Award 2009 to Encourage Scientists Using DNA Microarray	Your Story:  Nov 16 2009 6:23AM Matching: inc research
Toray Industries, Inc. Donates 3D-Gene(TM) Competition Award 2009...	Zibb:  Nov 16 2009 5:03AM Matching: inc research
Promote your company here: BioNewsCast - Press Release Distribution	→View more INC Research news.

INC Research Patents:
US Patent No.	Title
6709464	Cross-linked ultra-high molecular weight polyethylene for medical implant use
6006099	System and method for private radio communication

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 198 times since April 2007, the link to the organisation's website has been followed 36 times

Search for more companies in Raleigh

Search for more companies in North Carolina

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for INC Research